Home Research Feeds The Rumen Microbiota Contributes to the Development of Mastitis in Dairy Cows

The Rumen Microbiota Contributes to the Development of Mastitis in Dairy CowsOriginal paper

Researched by:

  • Karen Pendergrass

Last Updated: 2026-07-04

Karen Pendergrass
Karen Pendergrass

Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.

Read More
Location
China
Sample Site
Milk
Species
Bos taurus

What was studied?

Researchers examined whether rumen microbiota contribute to mastitis in dairy cows, using a subacute rumen acidosis (SARA) model. Holstein Frisian cows were fed a high-concentrate diet for 8 weeks to induce SARA.

How was it studied?

The team analyzed mammary gland inflammation alongside bacterial communities in rumen fluid, feces, and milk. They also tested oral administration of Stenotrophomonas in lactating mice to assess whether it could induce mastitis directly.

What did they find?

SARA cows developed mastitis symptoms, systemic inflammation, and increased permeability of the blood-milk, gut, and rumen barriers. Gut-derived lipopolysaccharides (LPS) translocated into the blood and accumulated in the mammary glands, and Stenotrophomonas abundance rose in the rumen of SARA cows. Oral Stenotrophomonas administration induced mastitis in lactating mice.

Why it matters

The findings challenge the traditional view that mastitis arises only from exogenous mammary infection, pointing instead to an endogenous rumen-to-mammary pathway. This suggests rumen microbiota could be a target for new mastitis therapies in dairy cattle.

Join the Roundtable

Contribute to published consensus reports, connect with top clinicians and researchers, and receive exclusive invitations to roundtable conferences.

Join the Waitlist and help shape the future of microbiome medicine.